SCHEMBL444378

SCHEMBL444378

O=C(O)CCCOCCCC(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.62
LMNA P02545 4/20 0.59
SLC22A6 Q4U2R8 2/20 0.59
NFKB1 P19838 2/20 0.56
PMP22 Q01453 1/20 0.56
ALDH1A1 P00352 2/20 0.50
CAMK2A Q9UQM7 1/20 0.50
GABRR3 A8MPY1 1/20 0.48
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
HDAC3 O15379 1/20 0.48
GABBR2 O75899 1/20 0.48
CYP1A2 P05177 1/20 0.48
THRB P10828 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRR1 P24046 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRR2 P28476 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15721716 0.97 TSHR (0.60) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL29211769 0.97 TSHR (0.60) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL28308008 0.97 TSHR (0.60) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL4068458 0.94 LMNA (0.61) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL15721706 0.92 TSHR (0.56) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL18073440 0.92 TSHR (0.56) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL6901767 0.92 TSHR (0.63) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL16011444 0.92 TSHR (0.63) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL8746939 0.92 TSHR (0.63) TSHRLMNASLC22A6NFKB1PMP22
SCHEMBL6900901 0.92 TSHR (0.63) TSHRLMNASLC22A6NFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096734-A1 MICROCAPSULES FMC CORPORATION (US) 2025-05-08 WO claimed
CN-119828414-A Black photoresist composition, preparation method and application thereof 深圳市容大感光科技股份有限公司 2025-04-15 CN claimed
CN-110642682-A Synthesis method of 5-oxaazelaic acid 上海吉奉生物科技有限公司 2020-01-03 CN claimed
EP-1426351-B1 PROCESS FOR PREPARATION OF 2,2,2-TRIFLUOROETHANOL TOSOH F TECH INC (JP) 2013-06-19 EP claimed
US-7208641-B2 Method for producing 2,2,2-trifluoroethanol TOSOH F-TECH, INC. (JP) 2007-04-24 US claimed
US-20040254406-A1 Method for producing 2,2,2-trifluoroethanol TOSOH F-TECH, INC. (JP) 2004-12-16 US claimed
CN-1551861-A Method for producing 2,2, 2-trifluoroethanol ������������ʽ���� 2004-12-01 CN claimed
EP-1426351-A1 PROCESS FOR PREPARATION OF 2,2,2-TRIFLUOROETHANOL Tosoh F-Tech, Inc. (JP) 2004-06-09 EP claimed
EP-0928809-B1 POLYSACCHARIDE DERIVATIVE/MAGNETIC METAL OXIDE COMPOSITE MEITO SANGYO KK (JP) 2003-10-22 EP claimed
US-6398857-B1 ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS XEROX CORPORATION 2002-06-04 US claimed
US-6395077-B1 INKS WITH BENZOYLBENZOIC ACID AND COLORS XEROX CORPORATION 2002-05-28 US claimed
US-6165378-A Polysaccharide derivative/magnetic metal oxide composite MEITO SANGYO KABUSHIKI KAISHA (JP) 2000-12-26 US claimed
EP-0928809-A1 POLYSACCHARIDE DERIVATIVE/MAGNETIC METAL OXIDE COMPOSITE MEITO SANGYO KABUSHIKI KAISHA (JP) 1999-07-14 EP claimed
US-5777003-A Redispersible polymer powder composition comprising cyclodextrins or cyclodextrin derivitaves WACKER-CHEMIE GMBH (DE) 1998-07-07 US claimed
EP-0791033-B1 REDISPERSABLE POLYMER POWDER COMPOSITIONS CONTAINING CYCLODEXTRIN OR CYCLODEXTRIN DERIVATIVES WACKER CHEMIE GMBH (DE) 1998-07-01 EP claimed
EP-0450092-B1 ORGANIC MAGNETIC COMPOSITE MEITO SANGYO KK (JP) 1996-05-08 EP claimed
US-5204457-A Used in nuclear magnetic resonance imaging; forming carboxy-alkylether of a polysaccharide and complexing with magnetic metal oxide MEITO SANGYO KABUSHIKI KAISHA (JP) 1993-04-20 US claimed
EP-0450092-A1 ORGANIC MAGNETIC COMPOSITE MEITO SANGYO KABUSHIKI KAISHA (JP) 1991-10-09 EP claimed
JP-3134001-A None JP disclosed
US-4001199-A Novel polypeptides useful for treating diabetes and hypercholesteremia TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254406-A1 Method for producing 2,2,2-trifluoroethanol HAO2, EBP, ADRB2 TSHR 1204/4885LMNA 4722/4885SLC22A6 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.